U.S. flag

An official website of the United States government

NC_000006.11:g.(43550879_43555008)_(43565603_43568724)del AND Xeroderma pigmentosum

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Dec 7, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002510287.1

Allele description [Variation Report for NC_000006.11:g.(43550879_43555008)_(43565603_43568724)del]

NC_000006.11:g.(43550879_43555008)_(43565603_43568724)del

Gene:
POLH:DNA polymerase eta [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
6p21.1
Genomic location:
Chr6: 43550879 - 43568724 (on Assembly GRCh37)
Preferred name:
NC_000006.11:g.(43550879_43555008)_(43565603_43568724)del
HGVS:
NC_000006.11:g.(43550879_43555008)_(43565603_43568724)del

Condition(s)

Name:
Xeroderma pigmentosum (XP)
Synonyms:
Xeroderma pigmentosa
Identifiers:
MONDO: MONDO:0019600; MedGen: C0043346

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002819315Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Likely pathogenic
(Dec 7, 2022)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV002819315.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Variant summary: The variant identified by MLPA or other technology involves the deletion of exons 4-5 in the POLH gene. A presumed nomenclature of c.(272+1_273-1)_(660+1_661-1)del has been designated for the purposes of this classification. Although exact breakpoints of this deletion are not known, it is expected to result in a frameshift in the POLH gene, a known mechanism of disease. The variant was absent in 21668 control chromosomes (gnomAD Structural Variants dataset). To our knowledge, no occurrence of c.(272+1_273-1)_(660+1_661-1)del in individuals affected with Xeroderma Pigmentosum and no experimental evidence demonstrating its impact on protein function have been reported. Deletion of exon 5, which is also expected to cause a frameshift in the POLH gene, has been catagorized as disease causing in HGMD (accession: CG024995). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jan 21, 2023